Summary & Overview
HCPCS L8679: Implantable Neurostimulator Pulse Generator
HCPCS Level II code L8679 identifies an implantable neurostimulator pulse generator, a surgically implanted device used for neuromodulation therapies. These devices are central to care pathways for chronic pain, movement disorders, and other neurologic conditions where electrical stimulation of neural structures is indicated. Nationally, billing for implantable neurostimulators involves complex device coding and facility-based procedural claims that intersect with medical necessity determinations, device supply policies, and coverage criteria across major payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and what aspects of reimbursement and billing are commonly associated with L8679 claims. The publication summarizes expected benchmarking areas such as payer coverage patterns, claim adjudication considerations, and common service line implications for surgical implantations.
This document provides practical reference material for coding teams, billing managers, and policy analysts seeking an authoritative description of HCPCS Level II code L8679, the service it represents, and the payer landscape relevant to national billing and coverage discussions. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code L8679 describes an implantable neurostimulator, pulse generator, any type. This device is a surgically implanted, battery-powered pulse generator used to deliver electrical stimulation to nervous tissue for neuromodulation therapies.
Service type: Implantable medical device — neurostimulation/pulse generation
Typical site of service: Inpatient or outpatient surgical settings, ambulatory surgery centers, or hospital operating rooms for device implantation procedures
Clinical & Coding Specifications
Clinical Context
A 55-year-old patient with chronic, refractory neuropathic pain following failed conservative therapies is evaluated for implantation of an implantable neurostimulator pulse generator. The multidisciplinary workflow includes preoperative assessment by a pain medicine or neurosurgery specialist, informed consent discussing device risks and benefits, preoperative imaging and stimulation trial if indicated, device implantation under monitored anesthesia care or general anesthesia in an outpatient surgical center or hospital operating room, intraoperative testing of lead placement and stimulation parameters, wound closure and device programming, and postoperative follow-up for wound check, device interrogation, and long-term programming adjustments. Typical sites of service include an ambulatory surgery center (ASC), hospital outpatient department, or inpatient operating room depending on patient comorbidities, anesthesia needs, and payer requirements.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier required/Not otherwise specified | Rarely used; baseline when no specific modifier applies |
11 | Primary procedure | When the implant of the pulse generator is the primary service on the claim |